Actively Recruiting
Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)
Led by Institut Curie · Updated on 2026-04-15
35
Participants Needed
1
Research Sites
244 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Assessment of the relevance of a new medical imaging test, FAPI PET, which could detect progression or relapse earlier than other tests currently available. Ultimately, it could enable early forms of pancreatic cancer to be detected and used for screening. In addition to the usual examinations prescribed, FAPI PET scans will be repeated at several points in the treatment process. All study patients must first have been included in the Homing cohort (NCT 04363983, APHP promotion). Clinical characteristics, judgement criteria and results of biological or imaging examinations carried out as part of this cohort will be shared. Patient follow-up and participation in the study ends when conventional imaging (CT and MRI) shows disease progression, relapse or death.
CONDITIONS
Official Title
Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cyto/histologically proven pancreatic ductal adenocarcinoma (PDAC)
- Non-metastatic PDAC confirmed by CT scan and MRI within the last month
- Current enrollment in the HoMING prospective cohort (NCT04363983)
- Age greater than 18 years
- Affiliated with a social security scheme
- Signed informed consent form
You will not qualify if you...
- Under legal protection such as guardianship, curatorship, or safeguarding justice
- Pregnant or breastfeeding women
- Women of childbearing potential not using a highly effective method of contraception
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut Curie -site Saint-Cloud
Saint-Cloud, France, 92210
Actively Recruiting
Research Team
M
Marie-Emmanuelle LEGRIER
CONTACT
S
Sandra NESPOULOUS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here